Today: 17 March 2026
Browse Category

Stock Market 18 December 2025

Carvana Stock (CVNA) News and Forecast: S&P 500 Inclusion, Analyst Targets, and the 2026 Setup (Dec. 18, 2025)

Carvana Stock (CVNA) News and Forecast: S&P 500 Inclusion, Analyst Targets, and the 2026 Setup (Dec. 18, 2025)

Carvana shares rose 3.8% to around $463 Thursday after S&P Dow Jones Indices confirmed the company will join the S&P 500 before trading opens Dec. 22. The move comes as U.S. equities rallied on inflation data and as analysts debate Carvana’s valuation following a dramatic rebound. Index inclusion is expected to drive buying from passive funds.
18 December 2025
UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group shares traded around $326–$327 midday on Dec. 18, 2025, after a volatile year marked by a 32.6% price drop. A Reuters report highlighted possible sharp ACA premium hikes in 2026 and UnitedHealth’s warning that enrollment could fall by two-thirds if subsidies are not extended. Legislative uncertainty around ACA subsidies remains high.
18 December 2025
Amphenol Stock (NYSE: APH) News Today, Forecasts, and Analyst Views for Dec. 18, 2025

Amphenol Stock (NYSE: APH) News Today, Forecasts, and Analyst Views for Dec. 18, 2025

Amphenol shares traded near $129 on Dec. 18, 2025, after falling 2% the previous day, leaving the stock about 12% below its November high. Recent filings show the Czech National Bank raised its stake in Q3 while Dudley & Shanley cut holdings. Debate continues over whether Amphenol’s valuation remains justified amid AI and data-center optimism. Market cap stands near $156 billion.
18 December 2025
Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock (BIRK) Stock Slides on FY2026 Outlook as Tariffs and FX Bite, Despite a FY2025 Beat

Birkenstock shares fell 8% to $42.58 on Dec. 18 after the company posted record fiscal 2025 revenue of €2.1 billion and strong profit growth but issued cautious 2026 guidance citing tariff and currency pressures. The stock swung between $39.73 and $46.75 in heavy trading as investors reacted to margin concerns despite robust recent results.
Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics Stock (EWTX) Today: Why Shares Fell on Dec. 18, 2025, Plus Latest News, Analyst Forecasts, and Key Clinical Catalysts

Edgewise Therapeutics shares fell 8.8% to $20.35 on Thursday, with no new company news released that day. The stock traded between $20.33 and $22.81 on volume of about 1.25 million shares. EWTX remains 38% below its 52-week high and 92% above its 52-week low. The company’s recent updates include a December stock option grant and a November board appointment.
Accenture Stock (ACN) Slides After Q1 FY2026 Earnings Beat: AI Bookings Hit $2.2B, Guidance Holds, and Wall Street Weighs In (Dec. 18, 2025)

Accenture Stock (ACN) Slides After Q1 FY2026 Earnings Beat: AI Bookings Hit $2.2B, Guidance Holds, and Wall Street Weighs In (Dec. 18, 2025)

Accenture shares fell about 1% Thursday, trading near $270.84, after the company’s Q1 FY2026 revenue and earnings beat estimates but its Q2 guidance midpoint of $17.68 billion came in just under analyst forecasts. Quarterly revenue reached $18.7 billion, with new bookings at $20.9 billion and adjusted EPS at $3.94, up 10% year over year.
ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries shares fell 10.6% Thursday to $43.13 after reporting adjusted Q4 EPS of $0.88, missing consensus, though revenue rose 5.4% to $2.295 billion, beating estimates. The company cited a $0.26 per-share hit from self-insurance adjustments and announced a $275 million acquisition. UBS downgraded the stock, citing margin and leverage concerns.
Trump Executive Order Today (Dec. 18, 2025): Marijuana Rescheduling, CBD Expansion and the Other Orders Driving Headlines

Trump Executive Order Today (Dec. 18, 2025): Marijuana Rescheduling, CBD Expansion and the Other Orders Driving Headlines

President Donald Trump signed an executive order Thursday directing federal agencies to speed up the process of reclassifying marijuana from Schedule I to Schedule III. The order also calls for expanded medical research and signals a Medicare policy shift allowing some beneficiaries to use hemp-derived CBD products. The administration has not released the full text of the order.
18 December 2025
Texas Instruments Incorporated Stock (TXN) Today: New Sherman Fab Starts Production as Analysts Split on 2026 Outlook

Texas Instruments Incorporated Stock (TXN) Today: New Sherman Fab Starts Production as Analysts Split on 2026 Outlook

Texas Instruments began chip production at its new 300mm wafer fab in Sherman, Texas, on Dec. 18, 2025. TXN shares rose 1.77% to $177.58 after the announcement. Wall Street remains divided on the company’s outlook, citing both long-cycle recovery hopes and concerns over inventory and capital spending. The Sherman facility is part of TI’s push for greater manufacturing control and supply reliability.
18 December 2025
AI Stocks Today (Dec. 18, 2025): Micron Ignites the AI Chip Rally as OpenAI Funding Talk and Data-Center Financing Fears Keep Wall Street on Edge

AI Stocks Today (Dec. 18, 2025): Micron Ignites the AI Chip Rally as OpenAI Funding Talk and Data-Center Financing Fears Keep Wall Street on Edge

Micron shares jumped 13.5% to $255.95 by early afternoon Thursday after the company issued a strong profit outlook and highlighted high demand for AI memory chips. The Philadelphia SE Semiconductor Index rose about 3%. Nvidia, AMD, Microsoft, Alphabet, and Meta also posted gains. Softer U.S. inflation data further boosted sentiment, sending Treasury yields lower and supporting tech stocks.
Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed Stock (NASDAQ: INSM) Slides on Brensocatib Sinus-Trial Failure; Analysts Reset Forecasts

Insmed shares fell 16% Thursday after the company said its Phase 2b trial of brensocatib in chronic rhinosinusitis without nasal polyps failed to meet endpoints, prompting it to end development for that indication. The drug’s performance matched or trailed placebo on symptom scores. Insmed reported no new safety issues. The stock traded near $166.75 after hitting a low of $158.06.
US Stock Market Today (Dec. 18, 2025, 1:52 p.m. ET): Dow, S&P 500, Nasdaq Jump on Cooler CPI as Micron Ignites Tech Rebound

US Stock Market Today (Dec. 18, 2025, 1:52 p.m. ET): Dow, S&P 500, Nasdaq Jump on Cooler CPI as Micron Ignites Tech Rebound

U.S. stocks climbed Thursday afternoon after inflation data came in below expectations, reviving hopes for Fed rate cuts in early 2026. At 1:52 p.m. ET, the Dow rose 0.39%, the S&P 500 gained 1.06%, and the Nasdaq jumped 1.72%. Micron’s outlook steadied tech shares. The CPI report was clouded by missing October data due to a government shutdown.
Trump Kennedy Center Today: Board Votes to Rename Washington’s Kennedy Center the “Trump‑Kennedy Center” as Legal Questions Loom (Dec. 18, 2025)

Trump Kennedy Center Today: Board Votes to Rename Washington’s Kennedy Center the “Trump‑Kennedy Center” as Legal Questions Loom (Dec. 18, 2025)

The Kennedy Center’s board voted Thursday to rename the institution the “Trump‑Kennedy Center,” according to the White House. Press secretary Karoline Leavitt said the move recognizes Trump’s role in renovations and finances. The board’s authority to change the congressionally established name remains in dispute. Trump currently chairs the board of trustees.
18 December 2025
Top AI Stocks to Buy Today (Dec. 18, 2025): Nvidia, Microsoft, Amazon, Broadcom, Micron and More as AI Trade Rebounds

Top AI Stocks to Buy Today (Dec. 18, 2025): Nvidia, Microsoft, Amazon, Broadcom, Micron and More as AI Trade Rebounds

Micron shares jumped midday after a strong profit forecast tied to AI memory demand, lifting semiconductor and tech stocks. Wall Street rose on a cooler CPI print, though shutdown-related data issues cloud the inflation outlook. Amazon reorganized its AI leadership, and Meta’s Yann LeCun announced his departure. OpenAI is reportedly seeking up to $100 billion in new funding.
Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Stock News Today: UPST Jumps on Tech CU Partnership as Wall Street Weighs 2026 Outlook (Dec. 18, 2025)

Upstart Holdings shares rose about 8% to near $49 on December 18 after Technology Credit Union announced it will use Upstart’s AI platform for personal and auto refinance loans. Tech CU began lending through Upstart’s network in September. Trading volume was below average despite the price jump. Analyst sentiment on the stock remains split.
18 December 2025
Adobe Stock Forecast: ADBE Trades Around $356 as AI Firefly Momentum, New Lawsuit Risk, and Mixed Analyst Targets Collide (Dec. 18, 2025)

Adobe Stock Forecast: ADBE Trades Around $356 as AI Firefly Momentum, New Lawsuit Risk, and Mixed Analyst Targets Collide (Dec. 18, 2025)

Adobe shares traded at $355.67 Thursday, up 0.28%, after a volatile week marked by strong Q4 results and new AI product announcements. The stock remains down about 23% year-to-date. A proposed class action lawsuit alleges Adobe used pirated books to train its AI models, adding legal uncertainty. Analyst price targets range widely, from $270 to $605.
18 December 2025
BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies Stock (NYSE: BETA) Surges as BofA Raises Price Target and U.S. DOT Unveils Advanced Air Mobility Roadmap

BETA Technologies shares rose 6.83% to $29.88 on December 18 after Bank of America raised its price target to $37 and the U.S. Department of Transportation announced a national strategy for advanced air mobility. The stock, which debuted in November at $34 per share, touched an intraday high of $30.49. Trading volume was lighter than usual.
18 December 2025

Stock Market Today

  • Axa Upgraded to Buy by Zacks on Rising Earnings Estimates
    March 17, 2026, 2:11 PM EDT. Axa Sa (AXAHY) received a Zacks Rank #2 (Buy) upgrade due to an upward revision in earnings per share (EPS) estimates, signaling improved business prospects. The Zacks Rank system evaluates stocks based on earnings estimate trends, which strongly influence near-term stock prices. Institutional investors often adjust valuations and trading decisions based on these changes, underpinning stock price movements. For fiscal 2026, Axa's EPS is projected at $4.73, steady with the prior year, but recently analysts have raised their estimates. This positive earnings outlook and subsequent rating upgrade may boost investor interest and drive Axa's stock higher, highlighting the importance of monitoring earnings revisions as a market indicator.
Go toTop